BTIS
IONS icon

BB&T Investment Services’s Ionis Pharmaceuticals IONS Stock Holding History

BB&T Investment Services’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$27K Buy
536
+34
+7% +$1.86K ﹤0.01% 711
2017
Q3 		$25K Sell
502
-298
-37% -$15.6K 0.01% 672
2017
Q2 		$41K Hold
800
– – 0.01% 510
2017
Q1 		$32K Hold
800
– – 0.01% 462
2016
Q4 		$38K Buy
+800
New +$31.7K 0.03% 339

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BB&T Investment Services's IONS Position: Q4 2017 in Review

BB&T Investment Services increased its Ionis Pharmaceuticals (IONS) stake by 6.8% in Q4 2017, buying an estimated $1.86K and bringing the position to 536 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #711.

BB&T Investment Services first reported a position in IONS in Q4 2016 and has held it in 5 quarters since. The position peaked at $41K in Q2 2017. 316 funds tracked by Wall St. Rank hold IONS as of Q4 2017.

  • BB&T Investment Services held 536 shares of Ionis Pharmaceuticals worth $27K as of Q4 2017.
  • BB&T Investment Services bought 34 Ionis Pharmaceuticals shares in Q4 2017, an estimated $1.86K.
  • Ionis Pharmaceuticals made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #711 holding.
  • BB&T Investment Services first reported a position in Ionis Pharmaceuticals in Q4 2016 and has held it in 5 quarters since.
  • BB&T Investment Services's Ionis Pharmaceuticals position peaked at $41K in Q2 2017.
  • 316 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.